# US 2026/0091160 A1 · Synthetic hemocompatible vascular grafts manufactured from polyvinyl alcohol-based biomaterials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0091160 A1
- Document ID: US20260091160A1
- Status: Published application
- Kind: A1
- Application number: 19/339,507
- Filed: 2025-09-25
- Published: 2026-04-02
- Earliest claimed: 2024-09-27
- Inventors: Nedeljko Vladimira Gvozdic
- Web page: https://patentgrep.com/patent/US20260091160A1

## CPC

- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/34: Macromolecular materials
- A61L 27/58: Materials at least partially resorbable by the body
- B33Y 80/00: Products made by additive manufacturing
- C08L 29/04: Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

Synthetic hemocompatible vascular grafts manufactured from polyvinyl alcohol-based biomaterials containing crystalline segments of polyvinyl alcohol, which are long-term fully functioning vascular grafts that provide no activity towards immune systems in recognizing surfaces as foreign bodies that would normally lead to fibrosis, platelet activation and subsequent thrombi formation, and thus occlusion of the grafts.

## Claims

### Claim 1

A synthetic hemocompatible vascular graft manufactured from polyvinyl alcohol-based biomaterials, said polyvinyl alcohol-based biomaterials having a water content of at least 88 weight percent, a molecular weight equal to or greater than 500 g/mole, a molecular weight distribution of 2 to 6 units, a degree of hydrolysis of 99.5% or greater, a syndiotacticity of fifty percent or greater, a head-to-tail monomer orientation of 98 percent or higher, total branching of 1 percent or lower, total disordered stereotacticity of 70 percent or lower, and containing crystalline segments of polyvinyl alcohol.

### Claim 2 (depends on 1)

A synthetic hemocompatible vascular graft as claimed in claim 1 wherein said graft is reinforced with fibers.

### Claim 3 (depends on 1)

A synthetic hemocompatible vascular graft as claimed in claim 1 wherein the wall thickness of said grafts range from 200 to 1,500 μm.

### Claim 4 (depends on 1)

A synthetic hemocompatible vascular graft as claimed in claim 1 wherein said graft has pre-embedded sutures cohesively attached thereto.

### Claim 5

A process for manufacturing a synthetic hemocompatible vascular graft, said process comprising:
i) providing a polyvinyl alcohol polymer having a molecular weight equal to or greater than 500 g/mole;
ii) mixing said polyvinyl alcohol polymer with a mixed solvent in a vessel;
iii) heating said mixture of i) and ii) under a nitrogen blanket while stirring for at least 2 hours;
iv) forming said vascular graft;
v) cooling said vascular graft at less than 0° C. for at least 2 hours to form crystalline segments of polyvinyl alcohol material;
vi) allow said vascular graft to come to room temperature;
vii) extracting any remaining said solvent from said graft.

### Claim 6 (depends on 5)

The process as claimed in claim 5 wherein said mixed solvent is water and dimethylsulfoxide.

### Claim 7 (depends on 5)

The process as claimed in claim 5 wherein said mixed solvent is water and glycerin.

### Claim 8

A bio-erodible synthetic hemocompatible vascular graft manufactured from polyvinyl alcohol-based biomaterials, said polyvinyl alcohol-based biomaterials having a water content of at least 88 weight percent, a molecular weight of 500 g/mole or greater, and containing crystalline segments of polyvinyl alcohol.

### Claim 9 (depends on 5)

A synthetic hemocompatible vascular graft manufactured by the process as claimed in claim 5.

### Claim 10 (depends on 5)

A bio-erodible synthetic hemocompatible vascular graft manufactured by the process as claimed in claim 5.

### Claim 11 (depends on 1)

A synthetic hemocompatible vascular graft as claimed in claim 1 when coated, said coating selected from:
(i) an enzymatically stable non-bio-erodible polyvinyl alcohol hydrogel combined with enzymatically unstable bio-degradable biomaterial such as alginate, poly(lactic acid) homo-polymer, poly(lactic-co-glycolic acid) copolymer, and polyethylene glycol;
(ii) electrospun polyvinyl alcohol fibers combined with enzymatically unstable bio-degradable biomaterial such as alginate, poly(lactic acid) homo-polymer, poly(lactic-co-glycolic acid) copolymer, and polyethylene glycol;
(iii) a bio erodible cellular or non-cellular polyvinyl alcohol hydrogel.

### Claim 12 (depends on 1)

A reinforced composite vascular graft as claimed in claim 1 when manufactured by 3-D tissue printing.
